Lower GI 2016
Stockholm III Trial
Inclusion Criteria: clinically resectable RC < 15 cm from AV
1 Week
5x5 Gy
TME
4 to 8 Weeks
R
5x5 Gy
TME
4 to 8 Weeks
25 x 2 Gy
TME
Primary endpoint: Time to local recurrence, 840 pts to show equality (15% @ 5y, power 80%) Secondary: acute, late tox, QoL, overall survival
Made with FlippingBook